Pursuant to Regulation 30 of SEBI(LODR) Regulation 2015 we are hereby inform you that the board of director of the company at its meeting held on 24th November has approved the setting ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Johnson Pharmacare Ltd (formerly Sun and Shine Worldwide Limited) approved the setting up of a new Corporate Office at 1002, 10th Floor, Vikram Tower, Rajendra Place, New Delhi-110060, at its meeting held on 24th November 2025. The disclosure has been filed with BSE under SEBI LODR Regulation 30 to update the Stock Exchange's records with the correct corporate office address. The company has clarified that there is no change in the Registered Office, which remains in Ahmedabad, Gujarat. This is a routine administrative update and does not indicate any change in business operations or financial structure. The scrip code on BSE is 532154 with security ID JOHNPHARMA.
This is a purely administrative announcement with no direct financial or material impact on shareholders. The new Delhi office may signal a wider operational presence, but no business growth or earnings impact can be inferred from this filing alone.